
NPPA caps trade margins on 137 non-scheduled anti-cancer drugs at 30 per cent
The National Pharmaceutical Pricing Authority has capped trade margins at 30% of MRP on 137 anti-cancer drugs, including patented ones, with revised prices to take effect from 9 November 2026.
3 sources



